These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 30638084)

  • 1. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peanut Allergy: New Advances and Ongoing Controversies.
    Abrams EM; Chan ES; Sicherer S
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32303583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy approaches for peanut allergy.
    Kim EH; Patel C; Burks AW
    Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
    Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
    Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
    Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing therapies for peanut allergy.
    Bublin M; Breiteneder H
    Int Arch Allergy Immunol; 2014; 165(3):179-94. PubMed ID: 25531161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of allergen-specific immunotherapy for peanut allergy: a meta-analysis of randomized controlled trials.
    Sun J; Hui X; Ying W; Liu D; Wang X
    Allergy Asthma Proc; 2014; 35(2):171-7. PubMed ID: 24717795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
    Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
    Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on peanut allergy: Prevention and immunotherapy.
    Cook QS; Kim EH
    Allergy Asthma Proc; 2019 Jan; 40(1):14-20. PubMed ID: 30582491
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).
    Wang J
    Allergy Asthma Proc; 2020 Jan; 41(1):5-9. PubMed ID: 31888777
    [No Abstract]   [Full Text] [Related]  

  • 19. Peanut Allergy: New Developments and Clinical Implications.
    Commins SP; Kim EH; Orgel K; Kulis M
    Curr Allergy Asthma Rep; 2016 May; 16(5):35. PubMed ID: 27039393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.